Women with sickle cell disease (SCD) experience significant challenges with healthcare while struggling with both the ...

Women with SCD experience significant healthcare challenges, a study found, with researchers calling for training on ...

Columnist Oluwatosin Adesoye reflects on her thriving life as she turns 38 (and counting) with sickle cell disease.

Enlargement of the heart’s left upper chamber in sickle cell patients is associated with worse disease severity, per a new ...

The U.K.'s Black History Month presents an opportunity for sickle cell patients to combat false narratives, columnist Mary ...

Columnist Sylvia Amuta always told other caregivers that it's OK to take a break. But sometimes things are easier said than ...

Wilson explains how Pfizer's decision to withdraw Oxbryta from global markets could affect the sickle cell community.

Preschool-aged children with sickle cell disease with limited access to healthy food and transportation are at higher risk ...

Mitem Pharma acquired from Novartis worldwide rights to Desferal, commonly used to lower excessive iron levels induced by ...

Columnist Mary Shaniqua, returning from her post-wedding activities, has learned that stepping back from advocacy obligations ...

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.